ONTOLOGY REPORT - ANNOTATIONS
| Term: | dieldrin |
|
| Accession: | CHEBI:34696
|
browse the term
|
| Definition: | An organochlorine insecticide that has formula C12H8Cl6O. |
| Synonyms: | exact_synonym: | rel-(1R,2S,3S,6R,7R,8S,9S,11R)-3,4,5,6,13,13-hexachloro-10-oxapentacyclo[6.3.1.1(3,6).0(2,7).0(9,11)]tridec-4-ene |
| | related_synonym: | (1R,4S,4aS,5R,6R,7S,8S,8aR)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,6,7,8,8a-octahydro-6,7-epoxy-1,4:5,8-dimethanonaphthalene; (1aalpha,2beta,2aalpha,3beta,6beta,6aalpha,7beta,7aalpha)-3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-2,7:3,6-dimethanonaphtho[2,3-b]oxirene; 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4-endo-exo-5,8-dimethanonaphthalene; 2,7:3,6-Dimethanonaphth[2,3-b]oxirene, 3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-, (1aalpha,2beta,2aalpha,3beta,6beta,6aalpha,7beta,7aalpha)-; C12H8Cl6O; InChI=1S/C12H8Cl6O/c13-8-9(14)11(16)5-3-1-2(6-7(3)19-6)4(5)10(8,15)12(11,17)18/h2-7H,1H2/t2-,3+,4+,5-,6-,7+,10+,11-; InChIKey=DFBKLUNHFCTMDC-PICURKEMSA-N; [H][C@]12[C@H]3C[C@H]([C@@H]4O[C@H]34)[C@@]1([H])[C@@]1(Cl)C(Cl)=C(Cl)[C@]2(Cl)C1(Cl)Cl |
| | xref_casrn: | 60-57-1 |
| | xref: | ChEMBL:1314274 "ChEMBL COMPOUND"; ChemIDplus:60-57-1 "CAS Registry Number"; KEGG COMPOUND:60-57-1 "CAS Registry Number"; KEGG COMPOUND:C13718 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D004026 |
| | xref: | NIST Chemistry WebBook:60-57-1 "CAS Registry Number" |
|
|
dieldrin
|
| G |
Acvr1c |
activin A receptor, type IC |
|
multiple interactions |
ISO |
3 |
40,027,228 |
40,102,303 |
RGD:6480464 |
CTD |
| G |
Acvrl1 |
activin A receptor type II-like 1 |
|
multiple interactions |
ISO |
7 |
139,873,596 |
139,884,675 |
RGD:6480464 |
CTD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
decreases expression |
EXP |
3 |
114,867,357 |
114,869,680 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
affects expression |
EXP |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
affects expression |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrbk1 |
adrenergic, beta, receptor kinase 1 |
|
increases expression |
EXP |
1 |
206,873,002 |
206,892,868 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases activity |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases activity |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
multiple interactions |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Avpr1b |
arginine vasopressin receptor 1B |
|
increases expression |
EXP |
13 |
44,537,103 |
44,547,318 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases response to substance |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
increases expression |
EXP |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
decreases expression |
EXP |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdk15 |
cyclin-dependent kinase 15 |
|
affects expression |
EXP |
9 |
57,840,625 |
57,930,096 |
RGD:6480464 |
CTD |
| G |
Chgb |
chromogranin B (secretogranin 1) |
|
decreases expression |
EXP |
3 |
120,571,736 |
120,584,874 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
decreases expression |
EXP |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
affects expression |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
|
affects expression |
EXP |
3 |
76,301,988 |
76,309,729 |
RGD:6480464 |
CTD |
| G |
Chrm5 |
cholinergic receptor, muscarinic 5 |
|
increases expression |
EXP |
3 |
98,326,809 |
98,378,531 |
RGD:6480464 |
CTD |
| G |
Chrna2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
|
decreases expression |
EXP |
15 |
45,570,809 |
45,587,091 |
RGD:6480464 |
CTD |
| G |
Chrna3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
decreases expression |
EXP |
8 |
58,570,223 |
58,583,594 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
affects expression |
EXP |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrna5 |
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
|
decreases expression |
EXP |
8 |
58,538,002 |
58,566,388 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
increases expression |
EXP |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrnb4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
|
decreases expression |
EXP |
8 |
58,586,961 |
58,605,545 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases expression |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
increases expression |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
decreases expression |
EXP |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
increases expression |
EXP |
11 |
58,446,901 |
58,520,589 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
decreases expression |
EXP |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
multiple interactions |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
multiple interactions |
ISO |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
multiple interactions |
ISO |
7 |
1,858,057 |
1,877,353 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
affects expression |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf12 |
fibroblast growth factor 12 |
|
decreases expression |
EXP |
11 |
74,208,696 |
74,481,037 |
RGD:6480464 |
CTD |
| G |
Fgf17 |
fibroblast growth factor 17 |
|
decreases expression |
EXP |
15 |
51,038,529 |
51,044,118 |
RGD:6480464 |
CTD |
| G |
Fgf19 |
fibroblast growth factor 19 |
|
affects expression |
EXP |
1 |
205,324,890 |
205,328,178 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
decreases expression |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
decreases expression |
EXP |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf22 |
fibroblast growth factor 22 |
|
increases expression |
EXP |
7 |
11,463,299 |
11,465,189 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
affects expression |
EXP |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
affects expression |
EXP |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
increases activity |
EXP |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
multiple interactions |
EXP |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Fzd1 |
frizzled family receptor 1 |
|
increases expression |
EXP |
4 |
25,994,423 |
25,998,821 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled family receptor 2 |
|
increases expression |
EXP |
10 |
91,709,222 |
91,711,132 |
RGD:6480464 |
CTD |
| G |
Fzd3 |
frizzled family receptor 3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fzd6 |
frizzled family receptor 6 |
|
affects expression |
EXP |
7 |
74,562,307 |
74,594,014 |
RGD:6480464 |
CTD |
| G |
Fzd7 |
frizzled family receptor 7 |
|
affects expression |
EXP |
9 |
58,063,740 |
58,066,559 |
RGD:6480464 |
CTD |
| G |
Fzd9 |
frizzled family receptor 9 |
|
decreases expression |
EXP |
12 |
22,581,510 |
22,583,824 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
multiple interactions |
ISO |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
decreases expression |
EXP |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
multiple interactions |
ISO |
14 |
39,568,677 |
39,705,897 |
RGD:6480464 |
CTD |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
|
multiple interactions |
ISO |
10 |
27,602,085 |
27,819,145 |
RGD:6480464 |
CTD |
| G |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
|
decreases expression |
EXP |
1 |
109,047,399 |
109,277,756 |
RGD:6480464 |
CTD |
| G |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
|
increases expression |
EXP |
1 |
109,047,399 |
109,277,756 |
RGD:6480464 |
CTD |
| G |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
|
decreases expression |
EXP |
14 |
39,878,182 |
39,951,391 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
multiple interactions |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
decreases expression |
EXP |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gabrr1 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
|
affects binding |
ISO |
5 |
49,421,463 |
49,458,535 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases phosphorylation |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases phosphorylation |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gjb2 |
gap junction protein, beta 2 |
|
decreases expression |
EXP |
15 |
36,153,526 |
36,159,490 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
EXP |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
increases expression |
EXP |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gpx6 |
glutathione peroxidase 6 |
|
decreases expression |
EXP |
17 |
51,063,379 |
51,068,058 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA 1 |
|
increases expression |
EXP |
10 |
42,613,359 |
42,616,610 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
decreases expression |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
|
affects expression |
EXP |
16 |
10,473,353 |
11,202,161 |
RGD:6480464 |
CTD |
| G |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
|
decreases expression |
EXP |
5 |
144,842,374 |
145,058,047 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases uptake |
ISO |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
decreases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2c |
glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
affects expression |
EXP |
10 |
105,323,371 |
105,340,976 |
RGD:6480464 |
CTD |
| G |
Grin3b |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
|
affects expression |
EXP |
7 |
11,243,973 |
11,250,311 |
RGD:6480464 |
CTD |
| G |
Grina |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
increases expression |
EXP |
7 |
114,277,208 |
114,280,339 |
RGD:6480464 |
CTD |
| G |
Grm5 |
glutamate receptor, metabotropic 5 |
|
decreases expression |
ISO |
1 |
143,857,225 |
144,477,419 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
affects expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
increases expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
affects expression |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
affects expression |
EXP |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gstm6 |
glutathione S-transferase, mu 6 |
|
affects expression |
EXP |
2 |
203,504,228 |
203,509,002 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
increases expression |
EXP |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gsto2 |
glutathione S-transferase omega 2 |
|
affects expression |
EXP |
1 |
253,239,392 |
253,275,110 |
RGD:6480464 |
CTD |
| G |
Gstt3 |
glutathione S-transferase, theta 3 |
|
decreases expression |
EXP |
20 |
13,595,934 |
13,603,087 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
decreases expression |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr1d |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
|
affects expression |
EXP |
5 |
155,188,669 |
155,189,793 |
RGD:6480464 |
CTD |
| G |
Htr2b |
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
affects expression |
EXP |
9 |
84,840,026 |
84,852,984 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
affects expression |
EXP |
X |
31,012,921 |
31,244,127 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
decreases expression |
EXP |
8 |
52,161,147 |
52,173,514 |
RGD:6480464 |
CTD |
| G |
Htr3b |
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
|
decreases expression |
EXP |
8 |
52,198,432 |
52,228,238 |
RGD:6480464 |
CTD |
| G |
Htr5a |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
|
increases expression |
EXP |
4 |
2,707,261 |
2,716,944 |
RGD:6480464 |
CTD |
| G |
Htr5b |
5-hydroxytryptamine (serotonin) receptor 5B |
|
decreases expression |
EXP |
13 |
33,545,128 |
33,558,050 |
RGD:6480464 |
CTD |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
decreases expression |
EXP |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Nefh |
neurofilament, heavy polypeptide |
|
decreases expression |
EXP |
14 |
85,594,789 |
85,604,774 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
increases expression |
EXP |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nefm |
neurofilament, medium polypeptide |
|
increases expression |
EXP |
15 |
47,698,371 |
47,703,350 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngfrap1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
|
increases expression |
EXP |
X |
123,586,256 |
123,587,175 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Ntf4 |
neurotrophin 4 |
|
increases expression |
EXP |
1 |
95,885,577 |
95,888,408 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
increases expression |
EXP |
2 |
179,838,740 |
179,855,545 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
affects expression |
EXP |
17 |
11,494,463 |
11,811,654 |
RGD:6480464 |
CTD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
decreases expression |
EXP |
1 |
133,925,530 |
134,302,139 |
RGD:6480464 |
CTD |
| G |
Nts |
neurotensin |
|
increases expression |
EXP |
7 |
40,474,654 |
40,484,058 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
multiple interactions |
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Penk |
proenkephalin |
|
decreases expression |
EXP |
5 |
17,509,323 |
17,514,265 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
increases activity |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarg |
retinoic acid receptor, gamma |
|
increases expression |
ISO |
7 |
140,991,447 |
141,014,108 |
RGD:6480464 |
CTD |
| G |
Shbg |
sex hormone binding globulin |
|
multiple interactions |
EXP |
10 |
56,432,474 |
56,435,654 |
RGD:6480464 |
CTD |
| G |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
|
decreases expression |
EXP |
16 |
22,356,304 |
22,389,827 |
RGD:6480464 |
CTD |
| G |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
|
decreases expression |
EXP |
16 |
22,356,304 |
22,389,827 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
increases expression |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a3 |
solute carrier family 18 (vesicular acetylcholine), member 3 |
|
affects expression |
EXP |
16 |
7,969,738 |
7,972,599 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
multiple interactions |
ISO |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
affects expression |
EXP |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
decreases expression |
EXP |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
increases expression |
EXP |
X |
159,570,789 |
159,580,093 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
multiple interactions |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sstr3 |
somatostatin receptor 3 |
|
increases expression |
EXP |
7 |
116,495,750 |
116,502,948 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases expression |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac4 |
tachykinin 4 (hemokinin) |
|
increases expression |
EXP |
10 |
83,946,235 |
83,954,475 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases activity |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
decreases expression |
EXP |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tph1 |
tryptophan hydroxylase 1 |
|
increases expression |
EXP |
1 |
97,186,071 |
97,207,551 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases secretion |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
|
increases expression |
EXP |
6 |
143,347,748 |
143,416,680 |
RGD:6480464 |
CTD |
| G |
Wnt2 |
wingless-type MMTV integration site family member 2 |
|
decreases expression |
EXP |
4 |
43,649,783 |
43,689,596 |
RGD:6480464 |
CTD |
| G |
Wnt2b |
wingless-type MMTV integration site family, member 2B |
|
decreases expression |
EXP |
2 |
200,218,630 |
200,233,002 |
RGD:6480464 |
CTD |
| G |
Wnt3a |
wingless-type MMTV integration site family, member 3A |
|
affects expression |
EXP |
10 |
45,553,682 |
45,594,983 |
RGD:6480464 |
CTD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
affects expression |
EXP |
5 |
156,064,371 |
156,083,198 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
decreases expression |
EXP |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wnt6 |
wingless-type MMTV integration site family, member 6 |
|
increases expression |
EXP |
9 |
74,104,364 |
74,117,995 |
RGD:6480464 |
CTD |
| G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
|
decreases expression |
EXP |
4 |
125,541,281 |
125,586,167 |
RGD:6480464 |
CTD |
| G |
Wnt9a |
wingless-type MMTV integration site family, member 9A |
|
affects expression |
EXP |
10 |
45,613,668 |
45,641,488 |
RGD:6480464 |
CTD |
| G |
Wnt9b |
wingless-type MMTV integration site family, member 9B |
|
affects expression |
EXP |
10 |
92,880,020 |
92,901,641 |
RGD:6480464 |
CTD |
Term paths to the root
|